| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,401 |
TOV: ALX - Panel Declines to Make Declaration
|
21 May 2026 9:29AM |
$4.810 |
$5.100 |
risen by
6.03%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Panel declined to make a declaration of unacceptable circumstances.
- Diamond Infraco 1 Pty Ltd launched an off-market takeover bid for Atlas Arteria.
- The offer price was set to increase if a 45% interest threshold was reached.
- ASIC relief provided to extend the offer period if conditions met.
- DICO undertook not to exercise certain discretions without Panel's consent.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ClearVue Technologies Limited (CPV) ORDINARY FULLY PAID |
Industrials |
$43 |
CPV Secures A$305,000 Commercial Retrofit Project in Cyprus
|
21 May 2026 9:28AM |
$0.110 |
$0.140 |
risen by
27.27%
|
|
CPV - Price-sensitive ASX Announcement
Full Release
Key Points
- ClearVue secures A$305,000 contract for BIPV glazing in Cyprus.
- Project involves 800m²+ solar façade for Rio Business Centre.
- Estimated annual electricity generation of ~139 MWh.
- ClearVue's products selected for advanced engineering features.
- BIPV integration supports sustainable and energy-efficient design.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lion Selection Group Limited (LSX) ORDINARY FULLY PAID |
Financials |
$122 |
Quarterly Report for 3 months ended 30 April 2026
|
21 May 2026 9:27AM |
$0.845 |
$0.855 |
risen by
1.18%
|
|
| Nex Metals Exploration Limited (NME) ORDINARY FULLY PAID |
Materials |
$5 |
NME and WTAC form Gold Exploration JV
|
21 May 2026 9:27AM |
$0.019 |
$0.014 |
fallen by
26.32%
|
|
NME - Price-sensitive ASX Announcement
Full Release
Key Points
- WTAC owns 60% of the joint venture and provides all funding.
- NME owns 40% of the joint venture, focusing on project identification and management.
- The joint venture aims to develop gold mining opportunities in Western Australia.
- Jason Livingstone appointed to lead the joint venture's operations.
- WTAC Commercial Services is a preferred provider for the joint venture.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Locksley Resources Limited (LKY) ORDINARY FULLY PAID |
Materials |
$29 |
High-Grade Antimony Intervals Intersected at DAM
|
21 May 2026 9:27AM |
$0.120 |
$0.077 |
fallen by
35.83%
|
|
LKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden drilling at DAM confirmed high-grade antimony mineralisation below historic underground workings.
- The drilling intersected subvertical quartz-stibnite veins within granite gneiss and tonalite.
- Hole DADD0005A showed 4.0 metres grading 4.87% Sb, including an interval of 0.4 metres at 33.51% Sb.
- Hole DADD0004 returned an intercept of 1.4 metres grading 5.62% Sb.
- Locklsey believes results suggest a larger hydrothermal antimony system.
- Further work will focus on refining structural controls and ongoing targeting.
- The project aims at re-establishing domestic antimony supply chains in the U.S.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kuniko Limited (KNI) ORDINARY FULLY PAID |
Materials |
$6 |
High-Grade Gold & Silver at Commonwealth-Silica Hill
|
21 May 2026 9:26AM |
$0.035 |
$0.028 |
fallen by
20%
|
|
KNI - Price-sensitive ASX Announcement
Full Release
Key Points
- Kuniko Limited completed a successful Phase 1 diamond drilling program at Commonwealth-Silica Hill.
- High-grade gold and silver mineralisation was confirmed at Commonwealth Main and South.
- Drillhole CMKNI006 intersected 7.1m at 8.4 g/t Au and 42 g/t Ag, indicating continuity of high-grade mineralisation.
- Phase 2 drilling program to begin in early July with a focus on larger extensions and deeper targets.
- Geophysical consultants conducting regional targeting review for new discoveries.
- Commonwealth Project is part of the prolific Lachlan Fold Belt, a Tier-1 mining region.
- The project comprises Commonwealth Main and Silica Hill deposits, both of which show significant exploration potential.
- Kuniko is in a binding earn-in and JV agreement with Impact Minerals to earn up to 70% of the project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Midas Minerals Ltd (MM1) ORDINARY FULLY PAID |
Materials |
$232 |
Further Exceptional Copper and Silver Intercepts, Otavi
|
21 May 2026 9:26AM |
$0.890 |
$0.960 |
risen by
7.87%
|
|
MM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Midas Minerals Ltd reported further significant copper and silver intercepts at T-13 Deposit.
- Assay results were received for six infill holes on the T-13 Copper-Silver Deposit at Otavi Copper Project.
- Significant intercepts include 46.2m at 4.01% CuEq and 50.6m at 7.81% CuEq.
- The company operates five rigs with plans to add another at Otavi.
- Midas plans an MRE update for T-13 in 2026.
- Namibia is a favorable mining jurisdiction due to stable democracy and infrastructure.
- Midas holds options to acquire interests in several projects around Otavi.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$105 |
Island Adds Biodefence Leader as Filovirus Risks Escalate
|
21 May 2026 9:25AM |
$0.400 |
$0.355 |
fallen by
11.25%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Raymond Taylor appointed to drive Galidesivir development.
- Taylor has over 40 years of experience in drug development and biodefense.
- Galidesivir is a broad-spectrum antiviral targeting multiple high-consequence viruses.
- Taylor's appointment strengthens Island's US Government engagement capabilities.
- Galidesivir shows promise in Marburg and Ebola non-human primate studies.
- Existing US Strategic National Stockpile countermeasures are strain-specific, unlike Galidesivir.
- Appointment comes amid rising global concern over Ebola and related filoviruses.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$3,858 |
Update - Notification of buy-back - AMP
|
21 May 2026 9:25AM |
$1.570 |
$1.560 |
fallen by
0.64%
|
|
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$14 |
Rights Issue Offer Document
|
21 May 2026 9:24AM |
$0.013 |
$0.016 |
risen by
23.08%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- Offer document for a renounceable rights offer.
- Targets shareholders in New Zealand and Australia.
- Offer period: May 29, 2026, to June 17, 2026.
- Rights will not be quoted on NZX or ASX.
- Eligible shareholders can apply for shortfall shares.
- Issue price: NZ$0.013 or A$0.011 per share.
- Offer is governed by New Zealand law.
- Part of TruScreen's market expansion efforts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$14 |
Cleansing Notice
|
21 May 2026 9:23AM |
$0.013 |
$0.016 |
risen by
23.08%
|
|
| Bougainville Copper Limited (BOC) 1 KINA ORDINARY FULLY PAID |
Materials |
$106 |
Reinstatement to Quotation
|
21 May 2026 9:23AM |
$0.635 |
$0.265 |
fallen by
58.27%
|
|
BOC - Price-sensitive ASX Announcement
Full Release
Key Points
- Bougainville Copper Limited's (BOC) securities will resume trading.
- Suspension lifted following the lodgement of BOC's Annual Report.
- Reinstatement of trading effective from 21 May 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bougainville Copper Limited (BOC) 1 KINA ORDINARY FULLY PAID |
Materials |
$106 |
2025 Annual Report to shareholders
|
21 May 2026 9:23AM |
$0.635 |
$0.265 |
fallen by
58.27%
|
|
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$14 |
Corporate Action Notice
|
21 May 2026 9:21AM |
$0.013 |
$0.016 |
risen by
23.08%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- Truscreen Group Limited announced a corporate action involving a placement and bonus issue.
- The rights issue will include 149,465,065 rights with an entitlement ratio of 1 new for every 5 existing shares.
- Subscription price per equity security is NZ$0.013/A$0.011.
- The placement includes up to 71,428,571 equity securities at NZ$0.014/A$0.012 per security.
- Existing holders and related parties may participate, subject to shareholder approval.
- Purpose of issuance includes MDR compliance, African market registrations, and clinical evidence development.
- Lead Managers for the placement are SP Corporate Pty Ltd and Erity Capital Pty Ltd, with associated fees and broker options.
- Oversubscription is at the Directors' discretion and subject to shareholder approval.
- The placement aims to access a broader pool of investors and offers favorable pricing.
- Corporate action is aligned with NZX Listing Rule 4.2 and requires external approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$14 |
Option Extension Prospectus
|
21 May 2026 9:21AM |
$0.013 |
$0.016 |
risen by
23.08%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- TruScreen Group Limited is extending the expiry date of its existing options by offering new extended options.
- The offers include Extended Placement Options, Extended SPP Options, and Extended Broker Options.
- Each extended option has an exercise price of NZ$0.022 (A$0.02) and will expire on 17 July 2027.
- The offers are made to Australian Placement Optionholders, Australian SPP Optionholders, and the Joint Lead Managers.
- The company will not apply for quotation of the options on NZX or ASX.
- The offers are not expected to materially affect the control of the company.
- The offers are being made as a varied offer under the Financial Markets Conduct Act 2013 (NZ).
- The document serves as a transaction-specific prospectus as per Australian regulations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Global Long Short Fund Limited (GLS) ORDINARY FULLY PAID |
Financials |
$1,060 |
Change of Auditor
|
21 May 2026 9:19AM |
$1.770 |
$1.935 |
risen by
9.32%
|
|
| Prodigy Gold NL (PRX) ORDINARY FULLY PAID |
Materials |
$23 |
Board Changes
|
21 May 2026 9:19AM |
$0.075 |
$0.067 |
fallen by
10.67%
|
|
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$14 |
Investor Presentation
|
21 May 2026 9:18AM |
$0.013 |
$0.016 |
risen by
23.08%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- TruScreen focuses on AI-enabled real-time cervical cancer screening.
- FY26 sales reached NZD $2.4m with a 42% YOY growth.
- Targeting low and middle-income countries for market expansion.
- Less than 0.1% of the global cervical cancer screening market share.
- Strategic partnerships in China, India, and Indonesia.
- Recurring revenue model through Single Use Sensors.
- Device recognized for low infrastructure needs.
- Listed on ASX and NZX exchanges.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bubs Australia Limited (BUB) ORDINARY FULLY PAID |
Consumer Staple |
$76 |
Appointment of Non-Executive Director Lori Tauber Marcus
|
21 May 2026 9:18AM |
$0.093 |
$0.085 |
fallen by
8.60%
|
|
| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$11 |
Consolidation/Split - ADR
|
21 May 2026 9:18AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$14 |
Truscreen Launches Capital Raise of N$2.9 million
|
21 May 2026 9:18AM |
$0.013 |
$0.016 |
risen by
23.08%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- TruScreen launches NZ$2.943 million capital raise.
- Includes a placement and a rights offer.
- Funds to be used for MDR compliance and market expansion.
- Aims to accelerate new market development and public health participation.
- Rights offer not quoted on NZX or ASX but can be sold off-market.
- Key dates outlined for capital raise completion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orange Minerals NL (OMX) ORDINARY FULLY PAID |
Materials |
$10 |
Becoming a substantial holder
|
21 May 2026 9:17AM |
$0.064 |
$0.055 |
fallen by
14.06%
|
|
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,719 |
Update - Notification of buy-back - WHC
|
21 May 2026 9:15AM |
$8.190 |
$8.160 |
fallen by
0.37%
|
|
| Resolute Mining Limited (RSG) ORDINARY FULLY PAID |
Materials |
$2,373 |
Change in substantial holding
|
21 May 2026 9:15AM |
$1.190 |
$1.110 |
fallen by
6.72%
|
|
| Comet Ridge Limited (COI) ORDINARY FULLY PAID |
Energy |
$156 |
Reinstatement to Official Quotation
|
21 May 2026 9:14AM |
$0.105 |
$0.130 |
risen by
23.81%
|
|
COI - Price-sensitive ASX Announcement
Full Release
Key Points
- Reinstatement to quotation after suspension.
- Acquisition of Santos' 42.86% interest in Mahalo Gas Project.
- Immediate lifting of trading suspension.
- Strategic enhancement of project stake.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
